These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 25468252)

  • 1. Cryptogenic stroke, atrial fibrillation and primary prevention.
    Schattner A; Hadad A
    Eur J Intern Med; 2014 Dec; 25(10):e124. PubMed ID: 25468252
    [No Abstract]   [Full Text] [Related]  

  • 2. Proposed screening is too simple and not focused enough.
    Seligmann C
    BMJ; 2012 Mar; 344():e2257. PubMed ID: 22453880
    [No Abstract]   [Full Text] [Related]  

  • 3. New Appraisal of Atrial Fibrillation Burden and Stroke Prevention.
    Passman R; Bernstein RA
    Stroke; 2016 Feb; 47(2):570-6. PubMed ID: 26732565
    [No Abstract]   [Full Text] [Related]  

  • 4. Atrial fibrillation in patients with cryptogenic stroke.
    Gladstone DJ; Spring M; Dorian P; Panzov V; Thorpe KE; Hall J; Vaid H; O'Donnell M; Laupacis A; Côté R; Sharma M; Blakely JA; Shuaib A; Hachinski V; Coutts SB; Sahlas DJ; Teal P; Yip S; Spence JD; Buck B; Verreault S; Casaubon LK; Penn A; Selchen D; Jin A; Howse D; Mehdiratta M; Boyle K; Aviv R; Kapral MK; Mamdani M;
    N Engl J Med; 2014 Jun; 370(26):2467-77. PubMed ID: 24963566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and stroke risk stratification for atrial fibrillation: limitations and new possibilities.
    Lip GY
    Am Heart J; 2008 Jul; 156(1):1-3. PubMed ID: 18585489
    [No Abstract]   [Full Text] [Related]  

  • 6. Heart Rhythm Monitoring Strategies for Cryptogenic Stroke: 2015 Diagnostics and Monitoring Stroke Focus Group Report.
    Albers GW; Bernstein RA; Brachmann J; Camm J; Easton JD; Fromm P; Goto S; Granger CB; Hohnloser SH; Hylek E; Jaffer AK; Krieger DW; Passman R; Pines JM; Reed SD; Rothwell PM; Kowey PR
    J Am Heart Assoc; 2016 Mar; 5(3):e002944. PubMed ID: 27068633
    [No Abstract]   [Full Text] [Related]  

  • 7. [Impact of standardized MONitoring for Detection of Atrial Fibrillation in Ischemic Stroke].
    Häusler KG; Heuschmann PU; Kirchhof P; Laufs U; Nabavi D; Röther J; Veltkamp R; Endres M
    Dtsch Med Wochenschr; 2015 Jun; 140 Suppl 1():S5-6. PubMed ID: 26069047
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of cardioembolic stroke in patients with atrial fibrillation.
    Weber R; Diener HC; Weimar C
    Expert Rev Cardiovasc Ther; 2010 Oct; 8(10):1405-15. PubMed ID: 20936927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening, optimization, support: a call for stroke prevention in atrial fibrillation.
    Induruwa I; Liu W; Khadjooi K
    Br J Hosp Med (Lond); 2018 Aug; 79(8):424-425. PubMed ID: 30070947
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiology patient page: stroke prevention in atrial fibrillation.
    Ruff CT
    Circulation; 2012 Apr; 125(16):e588-90. PubMed ID: 22529067
    [No Abstract]   [Full Text] [Related]  

  • 11. Preventing stroke in patients with atrial fibrillation.
    Edds W; Newton W
    J Fam Pract; 2000 Jan; 49(1):8-9. PubMed ID: 10678330
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of atrial fibrillation burden in assessing thromboembolic risk.
    Zimetbaum P; Waks JW; Ellis ER; Glotzer TV; Passman RS
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1223-9. PubMed ID: 25516580
    [No Abstract]   [Full Text] [Related]  

  • 13. Managing the challenge of atrial fibrillation and stroke prevention in older people: new drugs or new approaches to improve outcomes?
    Fuller R; Dudley N
    Age Ageing; 2005 Jul; 34(4):413-4; author reply 414. PubMed ID: 15955767
    [No Abstract]   [Full Text] [Related]  

  • 14. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 15. [Modern risk assessment and stroke prevention in atrial fibrillation].
    Gerber B; Senn O
    Praxis (Bern 1994); 2011 Sep; 100(19):1161-72. PubMed ID: 21938710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymptomatic Atrial Fibrillation: The Case for Screening to Prevent Stroke.
    Ben Freedman S; Lowres N
    JAMA; 2015 Nov; 314(18):1911-2. PubMed ID: 26547457
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessing stroke risk in patients with AF.
    Marshall G; Rankin AC
    Practitioner; 2007 Jun; 251(1695):30, 33-4, 36 passim. PubMed ID: 17654873
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolonged cardiac monitoring for detection of paroxysmal atrial fibrillation after cerebral ischemia.
    Rabinstein AA
    Stroke; 2014 Apr; 45(4):1208-14. PubMed ID: 24619396
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary stroke prevention: a paradigm shift focusing on silent paroxysmal atrial fibrillation.
    Schattner A
    QJM; 2019 Apr; 112(4):247-249. PubMed ID: 29917150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New anticoagulants (dabigatran, apixaban, rivaroxaban) for stroke prevention in atrial fibrillation.
    Aguilar MI; Kuo RS; Freeman WD
    Neurol Clin; 2013 Aug; 31(3):659-75. PubMed ID: 23896498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.